Clinical trial
Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge…
NCT00435526 · Johns Hopkins Bloomberg School of Public Health, Other · Completed
Key facts
| NCT number | NCT00435526 |
|---|---|
| Title | Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I |
| Official title | Protective Efficacy of Orally Delivered Bovine Milk Immunoglobulin (BIgG) Specific for the Minor CFA/I Fimbrial Adhesin CfaE Against Challenge With H10407 Enterotoxigenic E. Coli (ETEC) Strain Expressing CFA/I |
| Acronym | BIgGI |
| Lead sponsor | Johns Hopkins Bloomberg School of Public Health, Other |
| Collaborators | Naval Medical Research Center U.S. Fed Walter Reed Army Institute of Research (WRAIR) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Biological |
| Interventions | anti-CFA/I bovine IgG, and anti-CfaE bovine IgG |
| Enrollment | 30 |
| Start date | Mar 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Feb 15, 2007 |
| Last update posted | Feb 15, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: